NewswireToday - /newswire/ -
Salt Lake City, UT, United States, 2009/10/22 - RemedyMD application supports Institute of Medicine’s Top 100 Priorities for Comparative Effectiveness Research and AHRQ grant initiatives.
RemedyMD, the leading provider of disease registry software, today announced the first nationwide Gastroesophogeal Reflux Disease (GERD) registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Aligned with the Institute of Medicine’s Top 100 Priorities for Comparative Effectiveness Research (CER), RemedyMD’s GERD registry tracks the effectiveness of upper endoscopy utilization and frequency for patients with gastroesophageal reflux disease. The registry includes all of the applications, data infrastructure, and tools that clinicians and researchers need to gather, synthesize and analyze both phenotypic and genotypic data simultaneously.
“Our experience has shown when you view and report across all data types at the same time, you discover patterns and associations that are indistinguishable using traditional methodologies” said Gary D. Kennedy, Founder and CEO of RemedyMD.
RemedyMD’s new GERD registry includes a comprehensive set of electronic data collection (EDC) forms that are specific to esophageal cancer research, ad hoc reporting capability, and pattern recognition tools that assist users in identifying the most effective treatment options.
In support of this initiative RemedyMD is seeking additional partners who have existing data that addresses the specific needs of GERD researchers. All institutions involved in comparative effectiveness research that are planning on submitting grant proposals for AHRQ funding are invited to visit our website.
• RemedyMD Resources;
• Resource Kit for Comparative Effectiveness Research;
• Three ways to leverage GERD Registry;
• Comparative Effectiveness Research;
• Disease Registry Software;
• Institute of Medicine’s Top 100 Priorities for CER.
RemedyMD® (remedymd.com) is the leading provider of specialized software applications, tools, and data necessary for comparative effectiveness research with more than 100 pre-built clinical, disease, and patient registry software applications. RemedyMD solutions are personalized to the institution, the clinical specialty, and to the individual provider’s preferences enabling researchers to identify new patterns, facilitate new discoveries, and improve medical outcomes.